Skip to main content
Sirio Pharma Co., Ltd. logo

Sirio Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 300791 ISIN · CNE100003NB0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,175 across all filing types
Latest filing 2026-01-05 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300791

About Sirio Pharma Co., Ltd.

https://www.siriopharma.com

Sirio Pharma Co., Ltd. is a global contract development and manufacturing organization (CDMO) specializing in dietary supplements and nutraceuticals. The company provides comprehensive services encompassing product formulation, manufacturing, and packaging. Its portfolio includes diverse delivery formats such as softgels, gummies, tablets, hard capsules, powders, and oral liquids. Sirio Pharma emphasizes innovation in delivery systems, offering specialized solutions like plant-based softgels and advanced probiotic formulations. The organization adheres to rigorous quality management systems and maintains multiple international certifications to meet global regulatory standards. Serving an international clientele, the company supports health and wellness brands through scalable production capacities and integrated supply chain solutions.

Recent filings

Filing Released Lang Actions
关于2025年第四季度可转债转股情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bond (可转债) conversion situation for the fourth quarter of 2025 by the company 仙乐健康科技股份有限公司. It details the number of bonds converted into shares, remaining convertible bonds, and changes in shareholding structure due to conversion and stock incentives. The document includes specific bond codes, conversion prices, and regulatory approval references. It is a formal disclosure about bond conversion and share changes, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive data about bond conversion and shareholding changes. This type of document fits best under Capital/Financing Update (CAP) as it updates on convertible bond conversions and related capital structure changes.
2026-01-05 Chinese
信息披露管理制度（2025年12月）
Governance Information Classification · 100% confidence The document is titled '信息披露管理制度' which translates to 'Information Disclosure Management System' and is issued by 仙乐健康科技股份有限公司. It extensively details the company's policies, procedures, and responsibilities regarding information disclosure, including legal compliance, disclosure timing, content standards, internal reporting, confidentiality, and accountability. It references laws and regulations such as the Company Law, Securities Law, and rules from the China Securities Regulatory Commission and Shenzhen Stock Exchange. The document is a comprehensive internal governance manual for managing information disclosure rather than a financial report, earnings release, or announcement. It does not contain financial statements, audit results, voting results, or capital changes. It is a governance-related document outlining internal rules and practices for disclosure. Therefore, the most appropriate classification is Governance Information (CGR). The document length (12,875 characters) and content confirm it is not a brief announcement or a report publication announcement but a full governance policy document.
2025-12-22 Chinese
关于修订公司部分规章制度的公告
Governance Information Classification · 90% confidence The document is an announcement from the company about revisions to some of its internal governance rules and regulations, including shareholder meeting rules and management compensation policies. It references compliance with the updated Corporate Governance Code (2025 revision) and states that the revised rules are published on the designated disclosure website. The document is a formal announcement of changes to governance practices rather than the governance report itself. It does not contain detailed governance structure or internal rules report but announces the revision and publication of such rules. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-12-22 Chinese
关于部分募集资金投资项目延期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the delay of certain investment projects funded by raised capital. It details the use of funds raised through convertible bonds, the progress of investment projects, and the decision to postpone the completion date of a digital information construction project. The document includes board and audit committee approvals and opinions from the sponsoring institution. It is focused on the status and changes related to the use of raised funds, not a full financial report or earnings release. The document length is 3734 characters, which is relatively short and reads like a formal announcement rather than a comprehensive report. The content aligns with updates on fundraising and capital usage, specifically about investment projects funded by raised capital. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-12-22 Chinese
高级管理人员薪酬管理制度（2025年12月）
Remuneration Information Classification · 95% confidence The document is titled '高级管理人员薪酬管理制度' which translates to 'Senior Management Compensation Management System'. It details the company's policies, principles, and procedures regarding the remuneration of senior management personnel. The content includes salary composition, management, payment, performance evaluation, and constraints related to senior management compensation. There is no financial data, no report of financial results, no voting results, no legal proceedings, no capital changes, and no regulatory certifications. The document is a governance-related policy document about executive compensation management. Therefore, it fits best under the category of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2025-12-22 Chinese
关于增加公司对子公司申请银行授信预计提供担保额度的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding an increase in the guarantee amount provided by the company to its subsidiary for bank credit application. It details board meeting resolutions, audit committee opinions, and specifics about the guarantee amounts and terms. There are no financial statements or comprehensive financial reports included, but rather a disclosure of a corporate action related to financing support and guarantees. This fits the category of a Capital/Financing Update (CAP) as it relates to changes in financing arrangements and guarantees provided by the company. The document length is about 5,000 characters, and it is not merely an announcement of a report publication but a substantive disclosure of a financing-related decision.
2025-12-22 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.